Clinical Trials in Baltimore

Showing 2421-2440 of 11,213 trials

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

NCT05560685

The key hypothesis for this study is that collection of the PRO surveys via the Outcomes4Me app is feasible, as measured by survey completion rates. In addition to informing feasibility, this study will provide information about symptom trajectories, symptom management interventions, and early endocrine therapy adherence and persistence. Patients with risk factors for adjuvant endocrine therapy non-adherence or early discontinuation will complete patient-reported outcome (PRO) surveys via smart phone app at baseline and 2, 4, 8 and 12 weeks after adjuvant endocrine therapy initiation. Since symptoms and side effects are a key driver of adjuvant endocrine therapy non-adherence and non-persistence, the investigators anticipate that enhanced detection of symptoms via use of PRO surveys will result in improved symptom management and, could thereby support treatment adherence and persistence. This pilot study will assess the feasibility of the PRO survey intervention. In this pilot study, feedback about the intervention will be obtained from patients and from members of the study teams and clinical teams caring for the patients who participate.

Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins10 participantsStarted Oct 2022

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States

Active Not RecruitingNA< 1 mile

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Ischemic StrokeSystemic Embolism

AtriCure, Inc.6,573 participantsStarted Jan 2023

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +140 more locations

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Find Trials by Condition in Baltimore

Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Expanded Access of Sotorasib

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors